{
  "ticker": "BNTC",
  "company_name": "Benitec Biopharma Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT06185673",
      "title": "A Study to Evaluate the Safety and Clinical Activity of Intramuscular Doses of BB-301 Administered to Subjects With Oculopharyngeal Muscular Dystrophy With Dysphagia",
      "status": "RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Oculopharyngeal Muscular Dystrophy",
      "start_date": "2023-11-28",
      "completion_date": "2040-11",
      "enrollment": 0,
      "sponsor": "Benitec Biopharma, Inc."
    },
    {
      "nct_id": "NCT03433027",
      "title": "A Study of BB-401 in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Head and Neck Squamous Cell Carcinoma",
      "start_date": "2018-03-15",
      "completion_date": "2020-04-06",
      "enrollment": 0,
      "sponsor": "Benitec Biopharma, Inc."
    }
  ],
  "summary": {
    "total_trials": 2,
    "by_phase": {
      "PHASE1, PHASE2": 1,
      "PHASE2": 1
    },
    "by_status": {
      "RECRUITING": 1,
      "COMPLETED": 1
    },
    "active_trials": 1,
    "completed_trials": 1,
    "conditions": [
      "Head and Neck Squamous Cell Carcinoma",
      "Oculopharyngeal Muscular Dystrophy"
    ],
    "lead_stage": "phase_2"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T14:00:07.859089",
    "search_query": "Benitec Biopharma Inc.",
    "url": "https://clinicaltrials.gov/search?term=Benitec+Biopharma+Inc."
  }
}